Skip to content

Application of high flow heated respiratory humidifier in the treatment of atelectasis after thoracoscopic pneumonectomy in adults

Application of high flow heated respiratory humidifier in the treatment of atelectasis after thoracoscopic pneumonectomy in adults

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100046665
Enrollment
Unknown
Registered
2021-05-26
Start date
2021-05-24
Completion date
Unknown
Last updated
2022-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atelectasis

Interventions

Experimental group:use a High Flow Heated Respiratory Humidifier for treatment
control group:Standard Oxygen Therapy

Sponsors

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. ASA grade 1-3; 3. BMI 18.5-24.9 kg/m2; 4. Underwent elective thoracoscopic pneumonectomy with intraoperative one-lung ventilation (OLV); 5. Agree and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Any lung disease, such as asthma, chronic obstructive pneumonia, lung abscess, recent respiratory infection, etc.; 2. Previous lung surgery history; 3. The surgical site covers the ultrasonic exploration area; 4. Contraindications to HFNC treatment : (1) Insufficient respiratory drive to tolerate intervals of noninvasive ventilation therapy; (2) Acute sinusitis, otitis media; (3) Epistaxis, which may cause gastric inhalation; (4) Certain conditions that may lead to the inhalation of gastric contents; (5) inability to clear respiratory secretions; (6) Hypotension or obvious intravascular hypovolemia; (7) Pneumothorax or mediastinal emphysema; (8) Recent craniocerebral injury or surgery. 5. Inability to tolerate HNFC or COT therapy: Respiratory failure (respiratory rate > 35 times/min,SpO2 120 times/min or more than 30% above the baseline value before treatment; If one or more criteria are met, re-intubation is performed and the patient is converted directly to mechanical ventilation (MV); 6. Any other patient that the Investigator determines is not suitable for this study.

Design outcomes

Primary

MeasureTime frame
Ultrasound score of nonoperative lung after oxygen therapy;

Secondary

MeasureTime frame
Ultrasound score of surgical side lung after oxygen therapy;Arterial carbon dioxide partial pressure;Arterial partial pressure of oxygen;Incidence of significant atelectasis after oxygen therapy;The incidence of hypoxia in the anesthetic resuscitation room;Minimum oxygen saturation in the anesthetic resuscitation room;Duration in anesthesia resuscitation room;length of stay;The incidence of postoperative respiratory events;

Countries

China

Contacts

Public ContactWang Sheng

Anhui Provincial Hospital, Wannan Medical College

iamsheng2020@ustc.edu.cn+86 18935701573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026